# KURA ONCOLOGY INC (KURA)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/KURA/

- Reporting holders: 5
- Reported value: $51.9K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $17.1K | 1,597 | 0.0% | 12 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $16.5K | 1,541 | 0.0% | 12 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $13.6K | 1,272 | 0.0% | 7 |
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $4.7K | 436 | 0.0% | 7 |
| [CoreCap Advisors, LLC](https://holderbook.com/funds/1902501-corecap-advisors-llc/) | $11 | 1 | 0.0% | 7 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 5 | $51.9K |
| Q2 2026 | 224 | $1.0B |
| Q1 2026 | 219 | $696.3M |
| Q4 2025 | 213 | $896.5M |
| Q3 2025 | 198 | $762.3M |
| Q2 2025 | 182 | $481.7M |
| Q1 2025 | 183 | $539.9M |
| Q4 2024 | 187 | $696.1M |
| Q3 2024 | 180 | $1.6B |
| Q2 2024 | 176 | $1.7B |
| Q1 2024 | 165 | $1.8B |
| Q4 2023 | 140 | $1.2B |